The global medical grade silicone rubber market size was valued at USD 563.2 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 6.3% from 2020 to 2027. Increasing demand from various applications such as disposables, catheters, surgical instruments, prosthetics and implants, and drug delivery systems are significantly driving the demand for medical-grade silicone rubber.
Growing global healthcare expenditure is further anticipated to create lucrative opportunities for medical-grade silicone rubber in the coming years. According to the U.S. Centers for Medicare and Medicaid Services, healthcare spending in the country is projected to witness a growth rate of 5.7% from 2020 to 2027, and reach approximately USD 6.0 trillion by 2027. Healthcare spending is anticipated to account for approximately 19.4% share of the nation’s gross domestic product by 2027 up from 17.9% in 2017.
The rise is expected to be fueled by the rising needs of the aging population (65 years of age or above), an increase in the prevalence of chronic disorders and diseases, infrastructure improvements, and technological advancements. This, in turn, is expected to drive the medical device market, thereby leading to an increase in the demand for medical-grade silicone rubber.
Rising demand for advanced healthcare services attributable to the availability of well-developed healthcare infrastructure and reimbursement coverage is anticipated to propel the growth of the medical devices sector in the U.S., which, in turn, is anticipated to fuel demand for medical-grade silicone rubber. In addition, the constantly rising patient population due to the surging number of road accidents is expected to fuel the need for surgeries, which may further create demand for medical-grade silicone rubber in surgical instrument applications.
The strengthening of the Western European economies is expected to result in an increased provision of healthcare expenditure in the annual budgetary proposals. In addition, the healthcare industry in the Northern European economies such as Germany, the U.K., and Sweden are projected to exhibit an increase in healthcare expenditure, thereby leading to a growth in the production of medical devices.
Medical grade silicone rubber usage is regulated by numerous agencies across the globe. There has been an upsurge in the number of regulations covering the usage of silicone rubber in implants and medical devices. The manufacturers are required to comply with stringent regulations to maintain their market position. In the U.S., the Federal Food Drug, and Cosmetic Act Regulation, mentioned in Chapter 5 of the act, governs medical devices. A few of the amendments are the Medical Device Amendments, 1950, Safe Medical Devices Act (1990), FDA Modernization Act, and many more. Manufacturers are required to keep important documentation that must be held with the manufacturer. They include industry standards, internal standards, FDA consensus standards, FDA guidance documents, and regulation preambles.
The liquid silicone rubber product segment led the market and accounted for more than a 62.0% share of the global revenue in 2019. Medical grade liquid silicone rubbers are comprised of bio-inert material that complies with standards such as ISO 10993, USP Class VI, and RoHS. It has the ability to be sterilized, flexible, and self-adhesive. In addition, it has tremendous stability and water repellence. Medical devices produced using medical-grade liquid silicone rubber (LSR) help to increase life expectancy as it reduces pain and is also widely used in making artificial joints and pacemakers.
Closures, rings, gaskets, catheters, stoppers, and cushioning pads are a few of the products manufactured with medical-grade LSR. The liquid silicone rubber market in the Asia Pacific is expected to witness significant growth owing to rising applications in implants and prosthetics, drug delivery devices, and disposables. In addition, the general hospital, medical and dental service industry is witnessing rapid expansion in the region. China, India, Vietnam, Japan, Singapore, and Australia are among the key countries undergoing rapid medical advancements.
The prosthetics and implants application segment led the market and accounted for more than 27.0% share of the global revenue in 2019. Rising demand for medical-grade silicone rubber for the replacement of arthritic or destroyed joints, prosthetic, and breast implants are significantly fueling the growth of the market for medical-grade silicone rubber.
In addition, the increasing number of knee replacement surgeries globally is projected to augment the demand for implants during the forecast period. This, in turn, is further anticipated to create lucrative opportunities for medical-grade silicone rubber in implants and prosthetics application segments.
Medical grade silicone rubber is formulated in gum stock or liquid and combined with additives specific to the function of the implantable device. LSR is used in liquid injection molding in order to create implantable parts of excellent flexibility and strength. The cure time is relatively less than High Consistency Silicone Rubber (HCR), which helps to reduce production costs.HCR is used in transfer molding to achieve specifications such as thin walls or complex shapes.
North America dominated the market and accounted for over 34.0% share of the global revenue in 2019. The increasing per capita healthcare spending in the form of health insurance in the U.S. has been one of the major trends impacting the market for medical-grade silicone rubber in North America. This is expected to augment the demand for implants and prosthetics, surgical instruments, disposable devices, catheters, and other medical devices over the coming years, thereby driving the demand for medical-grade silicone rubber in the region.
The increasing prevalence of lifestyle-related disorders and diseases in the region, including diabetes and cardiac arrests, has resulted in increased spending on healthcare by the population. This is expected to boost the demand for medical devices such as surgical instruments, catheters, and drug delivery systems, thereby driving the market for medical-grade silicone rubber over the forecast period. In addition, the constantly rising patient population, on account of the outbreak of COVID-19 at the community level, is projected to propel the need for various medical components, thereby boosting the demand for medical grade silicone rubber in the U.S.Furthermore, the presence of key manufacturers such as Dow Corning, Wacker Chemie AG, and Momentive Performance Materials Inc., in the region is expected to positively impact the growth of the market for medical grade silicone rubber over the forecast period.
The competitive rivalry among producers is high owing to the presence of several players in the market for medical-grade silicone rubber. The market comprises prominent and well-established players, who have collectively captured a larger portion of the market for medical-grade silicone rubber. The market players are involved in the production of medical-grade silicone rubber with unique performance characteristics in order to stay ahead of the competition.
Prominent players involved in the marketplace are continuously engaged in adopting various strategic initiatives such as the increase in production capacity, new product development, investments in research, and development activities. For instance, in December 2018, Wacker Chemie AG, announced to increase its global production capacity of medical-grade silicone rubber and reach 40,000 metric tons per year by 2021. Some of the prominent players in the medical-grade silicone rubber market include:
Dow Corning
Wacker Chemie AG
Momentive Performance Materials Inc.
KCC Corporation
Elkem Silicones
Shin-Etsu Chemical Co., Ltd.
NuSil Technology LLC
Wynca Group
Primasil
Saint-Gobain Performance Plastics
Report Attribute |
Details |
Market size value in 2020 |
USD 596.4 million |
Revenue forecast in 2027 |
USD 914.0 million |
Growth Rate |
CAGR of 6.3% from 2020 to 2027 |
Base year for estimation |
2019 |
Historical data |
2016 - 2018 |
Forecast period |
2020 - 2027 |
Quantitative units |
Volume in tons, revenue in USD million and CAGR from 2020 to 2027 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, region |
Regional scope |
North America; Europe; Asia Pacific; Central & South America; MEA |
Country scope |
U.S.; Canada; Mexico; Germany; France; U.K.; Italy; China; India; Japan; Australia; Brazil; Argentina; Saudi Arabia; UAE |
Key companies profiled |
Dow Corning; Wacker Chemie AG; Momentive Performance Materials Inc.; KCC Corporation; Elkem Silicones; Shin-Etsu Chemical Co., Ltd.; NuSil Technology LLC; Wynca Group; Primasil; Saint-Gobain Performance Plastics |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global medical grade silicone rubber market report on the basis of product, application, and region:
Product Outlook (Volume, Tons; Revenue, USD Million, 2016 - 2027)
Liquid Silicone Rubber
High Consistency Rubber
Application Outlook (Volume, Tons; Revenue, USD Million, 2016 - 2027)
Prosthetics & Implants
Disposables
Catheter
Surgical Instruments
Drug Delivery Systems
Others
Regional Outlook (Volume, Tons; Revenue, USD Million, 2016 - 2027)
North America
The U.S.
Canada
Mexico
Europe
Germany
France
The U.K.
Italy
Asia Pacific
China
India
Japan
Australia
Central & South America
Brazil
Argentina
Middle East & Africa
Saudi Arabia
UAE
b. The global medical grade silicone rubber market estimated at USD 563.2 million in 2019 and is expected to reach USD 596.4 million in 2020.
b. The global medical grade silicone rubber market is expected to grow at a compound annual growth rate of 6.3% from 2020 to 2027 to reach USD 914.0 million by 2027.
b. The liquid silicone rubber segment dominated the medical grade silicone rubber market with a share of 62.83% in 2019. Properties such as excellent flexibility and strength and less cure time as compared to high consistency rubber are fueling the product demand in medical applications.
b. Some key players operating in the medical grade silicone rubber market include Dow Corning, Wacker Chemie AG, Momentive Performance Materials Inc., KCC Corporation, Elkem Silicones, Shin-Etsu Chemical Co., Ltd., NuSil Technology LLC, and Wynca Group.
b. Key factors driving the medical grade silicone rubber market growth include increasing healthcare spending, aging population, increasing urbanization, and the associated emergences of lifestyle-related illnesses, such as lung cancer and heart disease.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."